- Telehealth Visits
Kate Cheng, MD
Pediatric Gastroenterology • Pediatric Transplant Hepatology- Telehealth Visits
Kate Cheng, MD
Pediatric Gastroenterology • Pediatric Transplant Hepatology- Telehealth Visits
On this page
About me
Dr. Kate Cheng is a pediatric gastroenterologist and liver specialist specializes in treating various liver diseases, liver transplantation and obesity.
Cheng's research focuses on optimizing care and minimizing complications for children who are waiting for a liver transplant. She also advocates for children through her work on collaborative multicenter research projects and by serving on national committees.
Cheng earned her medical degree at the Ohio State University College of Medicine. She completed a residency in pediatrics at the Indiana University School of Medicine, followed by fellowships in pediatric gastroenterology and pediatric transplant hepatology at UCSF.
Education
Board Certification
- Gastroenterology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Transplant Hepatology, UCSF School of Medicine -GME
- Pediatric Gastroenterology, UCSF School of Medicine -GME
Residency
- Pediatrics, Indiana University Hospitals School of Med - GME
School
- MD, Ohio State University College of Medicine/Health
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Pediatric Gastroenterology
- Pediatric Transplant Hepatology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.